Skip to content
Search

Latest Stories

The mystery of India's low coronavirus death rate

India, with its population of 1.3 billion people, has the world's second-highest number of coronavirus cases, now more than seven million, but far fewer reported deaths than other badly-hit countries.

The figures have baffled experts, with explanations ranging from the young population to immunity given by other endemic viral diseases and under-reporting.


Here are some of the questions and theories raised by India's pandemic statistics:

- What are the figures? -

India said on Sunday there had been 108,334 fatalities from Covid-19 since the first death was reported in mid-March.

The world's second-most populous nation has the lowest number of deaths per 100 confirmed cases -- the observed case-fatality ratio -- among the top 20 worst-affected nations at 1.5 percent, according to a Johns Hopkins University tally.

In comparison, the United States, the most infected country, has a death rate of 2.8 percent. India's number of deaths per 100,000 population is 7.73, compared with 64.74 in the United States.

- Younger population -

Older people suffering from conditions such as diabetes and heart disease have become a particular target of the pandemic but India has a young population with a median age of 28.4, according to the UN World Population Prospects report.

In comparison, France -- which has reported almost 700,000 cases and more than 32,000 deaths for a death rate of 4.7 percent -- has a median age of 42.3.

- Late start, strict lockdown -

The Indian government says the first infection was detected on January 30, with numbers passing 100 in mid-March.

By that time, the epidemic was already raging across Europe. Italy had reported more than 24,000 infections and almost 2,000 deaths, while France recorded nearly 5,500 cases and around 150 deaths.

Prime minister Narendra Modi ordered a nationwide lockdown from March 25 that severely limited movement. That gave India time to prepare for the pandemic, while experts say the strict lockdown may have helped doctors learn from the experiences of other countries.

"Many of the treatment protocols were much better stabilised (by that time), whether it was oxygen use or ICU use," Anand Krishnan, a community medicine professor at the All India Institute of Medical Sciences in New Delhi, told AFP.

- Possible immunity -

Virologist T. Jacob John and other experts told AFP it is possible that other viral diseases such as dengue fever, which is endemic in India, may have given the population some antibody protection against the coronavirus.

Others say it is also plausible that exposure to other milder coronaviruses could give some cross-immunity. But all experts say more research is needed into this line of defence.

- Under-counting -

India already does not count all deaths. The problem is more acute in rural areas where 70 percent of the population live. Many rural deaths are not recorded unless the person has been in a hospital.

This has been accentuated during the coronavirus. In many cities, tallies given by city governments and at cemeteries and crematoria do not match. Activists accuse some states of deliberately blaming other conditions for Covid-19 deaths.

"Our poor routine death surveillance system... misses many deaths in the first place," Bangalore-based community medicine expert Hemant Shewade told AFP. He reckons that only one in five deaths is recorded with a cause.

Shewade, who has been analysing India's official toll data, said many suspected Covid-19 deaths were not being recorded.

Government-conducted serological surveys -- which test blood for antibodies to estimate how many have fought off the virus -- indicate that 10 times the official number of people may have already been infected, meaning many deaths could have gone unreported, he added.

Meanwhile in some cases, the coronavirus may not be listed as the cause of death for patients with other medical conditions.

- How to boost accuracy -

Experts say greater toll accuracy is possible if is there is more testing, better recording of deaths and post-mortem examinations are carried out on suspected victims.

Monitoring excess mortality -- the number of deaths above the "normal" figure -- as well as deaths at home could also shed some light on the real toll, Shewade said.

Mumbai, the country's worst-hit city, found 13,000 excess deaths in March-July compared with the same period last year -- twice the number of reported virus deaths at that time, the Indian Express reported.

More For You

Prada 2026 sandals

Prada acknowledges Indian influence behind its Spring Summer 2026 men’s footwear

Instagram/prada/iStock

Prada finally acknowledges Kolhapuri chappals inspired 2026 sandals after Indian backlash over Milan show

Quick highlights:

• Prada confirms Indian roots behind 2026 ‘leather sandals’ after controversy
• Indian artisans and officials accused the brand of cultural appropriation
• The footwear resembles traditional Kolhapuri chappals with GI status
• Prada says designs are still in development and open to dialogue with India

Keep ReadingShow less
Anna Wintour

Wintour’s style of leadership earned her the nickname “Nuclear Wintour”

Getty Images

Anna Wintour steps down as editor of US Vogue after 37 years

Key points

  • Anna Wintour steps down as editor of US Vogue after 37 years
  • She will remain Vogue’s global editorial director and hold senior roles at Condé Nast
  • Wintour transformed US Vogue into a global fashion authority
  • The 75-year-old has received numerous honours, including the Presidential Medal of Freedom

End of an era at US Vogue

Anna Wintour has stepped down as the editor of US Vogue, bringing to a close a 37-year tenure that redefined the publication and saw her become one of the most influential figures in global fashion.

The announcement was made on Thursday (26 June) during a staff meeting in New York. Wintour, 75, will no longer oversee the day-to-day editorial operations of Vogue’s US edition. However, she will continue to serve as Vogue’s global editorial director and Condé Nast’s chief content officer, maintaining senior leadership roles across the company.

Keep ReadingShow less
Nadiya Hussain

She also reassured her followers that “exciting” new projects are on the way

Getty Images

“I won’t always be grateful” says Nadiya Hussain after BBC axes her cookery show

Key points

  • Nadiya Hussain confirms BBC will not renew her cookery series
  • Bake Off winner challenges expectations to remain “grateful”
  • She says hard work and talent, not luck, brought her success
  • Celebrities, including Annie Lennox and Fearne Cotton, show support

BBC ends decade-long collaboration with Bake Off star

Nadiya Hussain has spoken out after the BBC decided not to commission another cookery programme with her. The popular TV chef, who won The Great British Bake Off in 2015, shared her views on social media, stating that she “won’t always be grateful” and should not be expected to remain silent about career setbacks.

The decision ends a nearly 10-year working relationship between the broadcaster and Hussain, who has hosted several well-received cookery shows under the BBC banner. In her latest Instagram video, she addressed the public’s reaction and emphasised her right to expect more from her career.

Keep ReadingShow less
weight loss injections UK

The importance of vigilance as demand for these weight loss and diabetes drugs continues to grow

iStock

Hundreds report pancreas issues linked to weight loss injections as UK launches safety study

Key points

  • Almost 400 reports of acute pancreatitis linked to weight loss and diabetes jabs have been filed in the UK
  • Most cases involve popular GLP-1 drugs including Ozempic, Wegovy, and Mounjaro
  • Health officials are investigating possible genetic causes behind the side-effects
  • Patients hospitalised with pancreatitis encouraged to report symptoms via MHRA’s Yellow Card scheme
  • Adverse drug reactions cost the NHS an estimated £2.2bn annually

Health watchdog investigates spike in serious side-effects from GLP-1 drugs

UK health authorities have launched a study into the side effects of popular weight loss and diabetes drugs following a spike in reported cases of acute pancreatitis. Nearly 400 reports have been received via the Medicines and Healthcare products Regulatory Agency’s (MHRA) Yellow Card scheme, which monitors side effects and adverse reactions related to medicines and medical devices.

The medicines involved are GLP-1 receptor agonists – including semaglutide (marketed as Ozempic and Wegovy), liraglutide, and tirzepatide (branded as Mounjaro). The Yellow Card data shows that 181 of the cases involved tirzepatide alone.

Keep ReadingShow less
M&S launches strawberries

M&S’s latest offering taps into both tradition and innovation

The Wire

M&S launches strawberries and cream sandwich ahead of Wimbledon

Summary

  • M&S unveils limited edition strawberries and cream sandwich for £2.80
  • Inspired by Japanese 'sweet sandos', it features Red Diamond strawberries and whipped cream cheese
  • Available in stores now, found in the savoury sandwich aisle
  • Launch coincides with Wimbledon and British strawberry season
  • Wimbledon increases strawberries and cream price for first time in 15 years

New summer sandwich from M&S

Marks & Spencer has launched a limited edition M&S strawberry sandwich, combining classic British summer flavours with a Japanese twist. Priced at £2.80, the strawberries and cream sandwich is available in M&S stores now.

The dessert-style sandwich features M&S’s exclusive Red Diamond strawberries, whipped cream cheese, and sweetened bread. Despite its sweet contents, the product is found in the savoury sandwich section of M&S Food halls.

Keep ReadingShow less